ISIN | LU1240788064 |
---|---|
Valor Number | 28364403 |
Bloomberg Global ID | UBSSEQA LX |
Fund Name | UBS (Lux) Equity SICAV - Swiss Opportunity (CHF) (EUR) Q-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | This actively managed sub-fund invests at least two thirds of its assets in equities and equity rights of companies domiciled or chiefly active in Switzerland, regardless of market capitalisation. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). |
Peculiarities |
Current Price * | 214.88 EUR | 25.07.2025 |
---|---|---|
Previous Price * | 215.76 EUR | 24.07.2025 |
52 Week High * | 217.78 EUR | 03.03.2025 |
52 Week Low * | 186.85 EUR | 07.04.2025 |
NAV * | 214.88 EUR | 25.07.2025 |
Issue Price * | 214.88 EUR | 25.07.2025 |
Redemption Price * | 214.88 EUR | 25.07.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 57,971,274 | |
Unit/Share Assets *** | 1,435,167 | |
Trading Information SIX |
YTD Performance | +9.00% |
30.12.2024 - 25.07.2025
30.12.2024 25.07.2025 |
---|---|---|
YTD Performance (in CHF) | +8.30% |
30.12.2024 - 25.07.2025
30.12.2024 25.07.2025 |
1 month | +3.24% |
25.06.2025 - 25.07.2025
25.06.2025 25.07.2025 |
3 months | +5.40% |
25.04.2025 - 25.07.2025
25.04.2025 25.07.2025 |
6 months | +3.50% |
27.01.2025 - 25.07.2025
27.01.2025 25.07.2025 |
1 year | +8.07% |
25.07.2024 - 25.07.2025
25.07.2024 25.07.2025 |
2 years | +16.64% |
25.07.2023 - 25.07.2025
25.07.2023 25.07.2025 |
3 years | +25.27% |
25.07.2022 - 25.07.2025
25.07.2022 25.07.2025 |
5 years | +50.31% |
27.07.2020 - 25.07.2025
27.07.2020 25.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 9.64% | |
---|---|---|
Roche Holding AG | 9.63% | |
Nestle SA | 9.48% | |
Zurich Insurance Group AG | 8.59% | |
ABB Ltd | 4.70% | |
UBS Group AG Registered Shares | 4.66% | |
Swiss Re AG | 4.63% | |
Lonza Group Ltd | 4.53% | |
Swiss Life Holding AG | 4.34% | |
Compagnie Financiere Richemont SA Class A | 3.15% | |
Last data update | 31.05.2025 |
TER | 1.09% |
---|---|
TER date | 31.05.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.82% |
Ongoing Charges *** | 1.10% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |